Status:
COMPLETED
Cytomegalovirus (CMV) Viremia and Disease Occurrence in Pediatric Allogeneic Stem Cell Transplantation Recipients
Lead Sponsor:
New York Medical College
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Cytomegalovirus Infections
Eligibility:
All Genders
Up to 26 years
Brief Summary
The primary objective is to determine the incidence of CMV viremia and disease in pediatric allogeneic stem cell transplantation recipients who received ganciclovir prophylaxis up until day +100 by re...
Detailed Description
This will be a single center, retrospective chart review of all pediatric patients who underwent allogeneic stem cell transplant between June 29, 2011 and December 31, 2019 at Westchester Medical Cent...
Eligibility Criteria
Inclusion
- Retrospective chart review of all pediatric patients who underwent allogeneic stem cell transplant between June 29, 2011 and December 31, 2019 at Westchester Medical Center (WMC).
- ages 0-≤26 years
- received an allogeneic stem cell transplantation on the pediatric bone marrow transplant service including matched unrelated donor, matched sibling donor, haploidentical donor, umbilical cord donor
- received ganciclovir prophylaxis for ≥14 days
Exclusion
- None listed
Key Trial Info
Start Date :
September 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 15 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04478474
Start Date
September 15 2020
End Date
September 15 2022
Last Update
October 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Medical College
Valhalla, New York, United States, 10595